Lv1
50 积分 2023-11-13 加入
Pharmacokinetics, Safety, and Immunogenicity of a Biosimilar of Nivolumab (LY01015): A Randomized, Double-Blind, Parallel-Controlled Phase I Clinical Trial in Healthy Chinese Male Subjects
4天前
已完结
Pharmacokinetics, Safety, and Immunogenicity of a Biosimilar of Nivolumab (LY01015): A Randomized, Double-Blind, Parallel-Controlled Phase I Clinical Trial in Healthy Chinese Male Subjects
5天前
已关闭
A comparison of statistical methods for animal oncology studies
1个月前
已完结
Experimental design considerations and statistical analyses in preclinical tumor growth inhibition studies
1个月前
已完结
Corrigendum to “Safety assessment of commercial sanitary pads: Cytotoxicity, volatile organic compounds, and microplastics release”[J. Hazard. Mater. 497 (2025) 139702]
1个月前
已完结
Cachexia‐induced reprogramming of visceral organ metabolism by human pancreatic cancer xenografts
4个月前
已完结
Tumor‐Induced Splenic Remodeling: Mechanisms of Systemic Immunosuppression and Emerging Therapeutic Opportunities
4个月前
已完结
Cardiac Cachexia Revisited
4个月前
已关闭
Dissecting the progression of cardiac dysfunction in tumor-bearing mice
4个月前
已关闭
Inhibition of the PI3K/AKT signaling pathway contributes to the anti-renal cell carcinoma effects of deoxyelephantopin
4个月前
已关闭
皖公网安备34019202002308
